228 related articles for article (PubMed ID: 23261605)
1. Morphobase, an encyclopedic cell morphology database, and its use for drug target identification.
Futamura Y; Kawatani M; Kazami S; Tanaka K; Muroi M; Shimizu T; Tomita K; Watanabe N; Osada H
Chem Biol; 2012 Dec; 19(12):1620-30. PubMed ID: 23261605
[TBL] [Abstract][Full Text] [Related]
2. JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.
Kong D; Yamori T
Bioorg Med Chem; 2012 Mar; 20(6):1947-51. PubMed ID: 22336246
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of bioactive small molecule target through phenotypic screening.
Cho YS; Kwon HJ
Bioorg Med Chem; 2012 Mar; 20(6):1922-8. PubMed ID: 22153994
[TBL] [Abstract][Full Text] [Related]
4. Determining the mode of action of bioactive compounds.
Azad MA; Wright GD
Bioorg Med Chem; 2012 Mar; 20(6):1929-39. PubMed ID: 22300885
[TBL] [Abstract][Full Text] [Related]
5. Target identification of bioactive compounds.
Tashiro E; Imoto M
Bioorg Med Chem; 2012 Mar; 20(6):1910-21. PubMed ID: 22104438
[TBL] [Abstract][Full Text] [Related]
6. Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics.
Yamori T
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S74-9. PubMed ID: 12819939
[TBL] [Abstract][Full Text] [Related]
7. Targeting cancer using fragment based drug discovery.
Turnbull AP; Boyd SM
Anticancer Agents Med Chem; 2012 Jan; 12(1):40-8. PubMed ID: 21707503
[TBL] [Abstract][Full Text] [Related]
8. Recent progress in the discovery of small-molecule inhibitors of the HMT EZH2 for the treatment of cancer.
Verma SK; Knight SD
Future Med Chem; 2013 Sep; 5(14):1661-70. PubMed ID: 24047271
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells as a target population for drug discovery.
Bouvard C; Barefield C; Zhu S
Future Med Chem; 2014 Sep; 6(14):1567-85. PubMed ID: 25367391
[TBL] [Abstract][Full Text] [Related]
10. Compound classification using image-based cellular phenotypes.
Adams CL; Kutsyy V; Coleman DA; Cong G; Crompton AM; Elias KA; Oestreicher DR; Trautman JK; Vaisberg E
Methods Enzymol; 2006; 414():440-68. PubMed ID: 17110206
[TBL] [Abstract][Full Text] [Related]
11. High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery.
Christophe T; Ewann F; Jeon HK; Cechetto J; Brodin P
Future Med Chem; 2010 Aug; 2(8):1283-93. PubMed ID: 21426019
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
Xia Y; Choi HK; Lee K
Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a new bioactive molecule for neuroblastoma.
Leitão A; Schramm A; Eggert A
Chem Biol Drug Des; 2013 Aug; 82(2):233-41. PubMed ID: 23601248
[TBL] [Abstract][Full Text] [Related]
14. Privileged structures: efficient chemical "navigators" toward unexplored biologically relevant chemical spaces.
Kim J; Kim H; Park SB
J Am Chem Soc; 2014 Oct; 136(42):14629-38. PubMed ID: 25310802
[TBL] [Abstract][Full Text] [Related]
15. The emerging role of CXC chemokines and their receptors in cancer.
Vinader V; Afarinkia K
Future Med Chem; 2012 May; 4(7):853-67. PubMed ID: 22571611
[TBL] [Abstract][Full Text] [Related]
16. An integrated one-step system to extract, analyze and annotate all relevant information from image-based cell screening of chemical libraries.
Rabal O; Link W; Serelde BG; Bischoff JR; Oyarzabal J
Mol Biosyst; 2010 Apr; 6(4):711-20. PubMed ID: 20237649
[TBL] [Abstract][Full Text] [Related]
17. Small-world phenomena in chemical library networks: application to fragment-based drug discovery.
Tanaka N; Ohno K; Niimi T; Moritomo A; Mori K; Orita M
J Chem Inf Model; 2009 Dec; 49(12):2677-86. PubMed ID: 19961207
[TBL] [Abstract][Full Text] [Related]
18. Development of a high-content screening assay panel to accelerate mechanism of action studies for oncology research.
Towne DL; Nicholl EE; Comess KM; Galasinski SC; Hajduk PJ; Abraham VC
J Biomol Screen; 2012 Sep; 17(8):1005-17. PubMed ID: 22706350
[TBL] [Abstract][Full Text] [Related]
19. Approved Anti-cancer Drugs Target Oncogenic Non-coding RNAs.
Velagapudi SP; Costales MG; Vummidi BR; Nakai Y; Angelbello AJ; Tran T; Haniff HS; Matsumoto Y; Wang ZF; Chatterjee AK; Childs-Disney JL; Disney MD
Cell Chem Biol; 2018 Sep; 25(9):1086-1094.e7. PubMed ID: 30251629
[TBL] [Abstract][Full Text] [Related]
20. Finding Hsp90 inhibitors by drug repurposing: the power of chemical genetics.
Xiong M; Zhang HY
Drug Discov Today; 2012 Jun; 17(11-12):531-3. PubMed ID: 22469949
[No Abstract] [Full Text] [Related]
[Next] [New Search]
